Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Patel Sujal M, Chairman & CEO. Insider active across 1 company, notably Nautilus Biotechnology, Inc.. In total, 9 filings have been published. Breakdown: 9 buys · 0 sell. Total volume traded: €1.3m. History available since 30 November 2021. The latest transaction was disclosed on 4 March 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Patel Sujal M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
161,978 shares@ US$4.721550.5% of flowCommon StockSEC:0001808805-21-000027:0
Canonical exit: 28 Feb 2022 (T+90)
9 of 9 declarations
About Patel Sujal M
Patel Sujal M is Président-Directeur Général and is associated with Nautilus Biotechnology, Inc., where he is CEO, President, and Secretary. He has 9 filings in total, and across the 9 sampled filings, the transactions are acquisitions with total खरीद purchases of EUR 1341893 and no sales, between 2021-12-02 and 2026-03-04.